logo
logo
logo
logo
providencemedicalgrp 2021-11-26
img
The Comprehensive Diabetes Care Program at Providence medical Center offers complete outpatient services including diagnostic services. We have the best diabetes specialist doctor in Thornton, Book an appointment today!  
collect
0
Shivani Sharma 2021-11-01
img

The global chemiluminescence immunoassay market is expected to reach USD 10.67 billion by 2027, according to a new study by Polaris Market Research.

The report Chemiluminescence Immunoassay Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments {Automated and Semi-automated}, Consumables, Software & Services); By Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease); By End Use; By Regions; Segment Forecast, 2020 – 2027 gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global chemiluminescence immunoassay market is driven by few notable factors such as rapid surge in the COVID- 19 cases, the awareness among the people about timely medical attention, and rapidly improving healthcare infrastructure in terms of rapid testing, which in turn, boosting the chemiluminescence immunoassay industry growth.

Chemiluminescence immunoassay solutions are also used for detection of numerous severe diseases including autoimmune disease, cancer, and diabetes, among others.

Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/chemiluminescence-immunoassay-market/request-for-sample  The global chemiluminescence immunoassay industry is segmented on the basis of product, application, end-use, and region.

Based on application, the market is classified as therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease, autoimmune disease, and others.

collect
0
jhon kerry 2021-10-29
The global Home Infusion Therapy Market is anticipated to grow at a significant CAGR during the forecast period. Home infusion therapy is an integral part of professional practice in developed countries. Though the patients’ scenarios are different under various circumstances, a considerable amount of risk is always involved. The nature of home infusion therapy is not only limited to patient care and device, but also it actively involves accumulation of consumables and enactment of quality improvement and research activities. Medical practices inclined towards patient betterment are expected to gain a huge traction in the forecast period. Application segment includes endocrinology, parenteral nutrition, and hydration therapy.
collect
0
Dhirtek Business Research 2021-09-27

REQUEST A SAMPLE REPORTAccording to the latest research report published by Dhirtek Business Research, the global endocrinology drugs market report provides detailed information on the factors driving the growth of the endocrinology drugs market.

The COVID-19 has a significant impact on the global economy.

This pandemic is having an impact on various sectors of the economy.

It predicts that the global economy will suffer as a result of the loss of trillions of dollars.

The report includes a chapter that examines the effect of COVID-19 on the endocrinology drugs market in depth.To compete in a competitive market, the companies must identify product opportunities based on their strengths.

This study provides a platform for understanding the various exciting and rising prospects in the field of endocrinology drugs, and it will help every producer, distributor, or even user understand and succeed in this burgeoning industry.Obtain a Sample Report and the Table of Content for the Endocrinology Drugs Market Report: https://www.dhirtekbusinessresearch.com/market-report/Endocrinology-Drugs-Market/request-for-sample-reportStudy Goals and Objectives of Global Endocrinology Drugs MarketThe report provides information on the market impact of endocrinology drugs.

collect
1
Healthy PCOS 2021-11-11
img

According to a study by Gynecology Endocrinology, women with polycystic ovarian syndrome (PCOS) are 19 times more likely to have a magnesium deficiency.There are a number of reasons why magnesium deficiency is so common among women with PCOS.But it’s likely to be due to some combination between poor soil concentrations of magnesium that lead to magnesium deficient foods, stress, lack of fruits and vegetables, certain medications such as birth control, and insulin resistance.Benefits Of Magnesium For PCOSWhat Is Magnesium?Magnesium is the fourth most abundant mineral in the body.It is naturally present in many foods, added to other food products, available as a dietary supplement, and present in some medicines.Its importance is demonstrated through its involvement as a cofactor in more than 600 enzyme systems that regulate important reactions in the body.Notable reactions with which it is involved include:• Blood glucose control• Blood pressure regulation• Creating proteins from amino acids (protein synthesis); essential for muscle development• Regulating neurotransmitters (brain chemicals — responsible for your mood)• Converting food into energy (cellular energy production).All of the above reactions contribute to the health of your brain and body, which makes magnesium an essential mineral; especially for those who have PCOS and are likely to have a deficiency.Magnesium, then, is a core staple supplement for women with PCOS.However, it is not merely because of its involvement in reactions within your body.It’s also because of its ability to help a range of PCOS symptoms, some of which are seen as almost unbearable.Without further ado, let’s explore why you should consider supplementing with magnesium.

collect
0
Deepak Karde 2021-08-06

Endocrinology Drug Market Market Introduction & Scope:Introspective Market Research has conducted a thorough and extensive analysis of the global Endocrinology Drug Market market.

It is a complete research study and industry analysis of the market to understand the market influencing market demand, growth, trend analysis and factors.Also, it strategically profiles the key players and comprehensively analyzes their development, mergers and acquisition and the R investment done by the competitors.To define, describe and forecast the market by product type, market and key regions.The Endocrinology Drug Market market report comprises of:past acquisition strategies supportedactivities taken to remove competitive barriersactions data to resolve deficient data issueschanges in the market place (suppliers, trends, technologies)past acquisition historyLeading players involved in the Endocrinology Drug Market Market includes:Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, AbbVieTo identify the key drivers and the competitors’ insights, Request a Sample @:https://introspectivemarketresearch.com/request/11035Global Endocrinology Drug Market Market: Key CatalystsIntrospective Market Research in a recent report focused on providing all the market potentials and drivers influencing the market.

The opportunities and constraints for the market are presented after reviewing all market estimates and details provided by reliable sources for the Endocrinology Drug Market market.

In addition to a detailed description of the key factors, the report provides a complete understanding of the challenges, opportunities and factors that are influencing the future market growth.The analysis also divides the Endocrinology Drug Market Market on the grounds of main product type:Oral, InjectionThe analysis also divides the Endocrinology Drug Market Market on the applications:Application 1, Application 2, OtherDriver Analysis: After surveys, data mining and collecting from paid and real sources, the results for the global Endocrinology Drug Market market are presented with the utmost understanding and factors considered for the market growth.

IMR's reports will be updated over the next few years, providing customers with accurate data and value on market trends using the same size and forecast variable.Get Discount on Full Report of Endocrinology Drug Market Market @: https://introspectivemarketresearch.com/discount/11035Restraints: The specific types of issues a manufacturer or supplier is dealing with in relation to the global Endocrinology Drug Market market is analyzed in the report to ensure that customers have a clear and easy-to-understand overview of the market and trends.

The IMR market research report provides a detailed analysis of mergers and acquisitions, providing opportunities to win customers in the industry domain.The full overview of the report is aimed at providing an analysis of the market to help customers know a detailed version of the threats of new entrants, supply and demand chain analysis, and the challenges facing the market.

collect
2
Wiseguy1011 2021-07-14

Due to the high popularity of this product/service in North America and Asia, the growth trend of Endocrinology Drug in recent years and the growth of consumers' demand is expected to drive the global Endocrinology Drug market.ALSO READ:  http://www.marketwatch.com/story/global-endocrinology-drug-market-size-share-value-and-competitive-landscape-2020-2021-05-04Geographically, the global Endocrinology Drug market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.North America, Asia and Europe have significant position in the this market, big players operating in there.

The U.S. is accounting for a major share of the total Endocrinology Drug market in North America.Significant participants active in the global Endocrinology Drug market include: GSK, Novo Nordisk AS, Allergan, AstraZeneca PLC, Merck & Co, Sanofi SA, Roche, Bayer, Novartis, AbbVie Inc., Pfizer, Eli Lilly and Co....ALSO READ:  http://www.marketwatch.com/story/june-2021-report-on-global-bed-with-storage-market-size-share-value-and-competitive-landscape-2021-2026-2021-06-17Global Endocrinology Drug Market Segmentation:Endocrinology Drug market, by Endocrinology Drug type:Type 1Type 2Type 3…Endocrinology Drug market, by Application:Application 1Application 2Application 3…ALSO READ:  http://www.marketwatch.com/story/june-2021-report-on-global-iot-spending-in-manufacturing-market-overview-size-share-and-trends-2021-2026-2021-06-17Endocrinology Drug Market Research Report 2014-2026, by region:North AmericaThe U.S.CanadaEuropeGermanyUKFranceItalySpainRest of EuropeLatin AmericaMexicoBrazilArgentinaPan Asia PacificChinaJapanSouth KoreaSouth East Asia RegionIndiaAustraliaMiddle East and AfricaSaudi ArabiaUAEQatarEgyptNigeriaSouth AfricaRest of MEAThe database is running updated by a group of research experts to always reflect the latest trends and information.ALSO READ:  http://www.marketwatch.com/story/pre-packed-fruit-and-vegetables-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2020-2026-2021-06-21Table of Contents1.

Introduction1.1 Definition of the Market1.2 Research Purpose1.3 Scope of the Study1.4 Stakeholders1.5 Geography Coverage1.6 Currency Under Consideration1.7 Volume Units1.8 Review Cycle1.9 Summary and Key Findings of the Research2 Research Methodology2.1 Research Data2.1.1 Secondary Data2.1.2 Primary Data2.2 Market Size Estimation2.2.1 Bottom-Up Approach2.2.2 Top-Down Approach (Involves time, Space, and Persons)2.3 Data Triangulation2.4 Assumptions2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research2.6 Limitations of Our Study2.7 Scene Based Modeling2.8 Covid-19 Impact/Evaluation3.

Market Dynamics3.1 Driving Factors3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa3.1.2 Increasing Use of Endocrinology Drug by Different End-User/Applications3.2 Restraints and Challenges in the Market3.3 OpportunitiesALSO READ:  http://www.marketwatch.com/story/electric-bikes-and-folding-bikes-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2020-2026-2021-06-204.

Global Endocrinology Drug Market-Segmentation4.1 By Type4.1.1 Type 14.1.2 Type 24.1.3 Type 34.2 By End-User/Application Industry4.2.1 Application 14.2.2 Application 24.2.3 Application 34.3 By Geography4.3.1 North America Endocrinology Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)4.3.1.1 North America Endocrinology Drug Production from 2014-20204.3.1.2 North America Endocrinology Drug Consumption from 2014-20204.3.1.3 North America Endocrinology Drug Import and Export from 2014-20204.3.1.4 North America Endocrinology Drug Market Value ($) and Growth (%) by Type from 2019-20204.3.1.5 North America Endocrinology Drug Market Value ($) and Growth (%) by Application from 2019-20204.3.1.6 North America Endocrinology Drug Market Value ($) and Growth (%) by Countries from 2019-20204.3.1.7 Top North America Endocrinology Drug Participants Value ($) and Market Share (%) in 20194.3.2 Europe Endocrinology Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)4.3.2.1 Europe Endocrinology Drug Production from 2014-20204.3.2.2 Europe Endocrinology Drug Consumption from 2014-20204.3.2.3 Europe Endocrinology Drug Import and Export from 2014-20204.3.2.4 Europe Endocrinology Drug Market Value ($) and Growth (%) by Type from 2019-20204.3.2.5 Europe Endocrinology Drug Value ($) and Growth (%) by Application from 2019-20204.3.2.6 Europe Endocrinology Drug Market Value ($) and Growth (%) by Countries from 2019-20204.3.2.7 Top Europe Endocrinology Drug Participants Value ($) and Market Share (%) in 20194.3.3 Asia-Pacific Endocrinology Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)4.3.3.1 Asia-Pacific Endocrinology Drug Production from 2014-20204.3.3.2 Asia-Pacific Endocrinology Drug Consumption from 2014-20204.3.3.3 Asia-Pacific Endocrinology Drug Import and Export from 2014-20204.3.3.4 Asia-Pacific Endocrinology Drug Value ($) and Growth (%) by Type from 2019-20204.3.3.5 Asia-Pacific Endocrinology Drug Value ($) and Growth (%) by Application from 2019-20204.3.3.6 Asia-Pacific Endocrinology Drug Value ($) and Growth (%) by Countries from 2019-20204.3.3.7 Top Asia-Pacific Endocrinology Drug Participants Value ($) and Market Share (%) in 20194.3.4 Latin America Endocrinology Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)4.3.4.1 Latin America Endocrinology Drug Production from 2014-20204.3.4.2 Latin America Endocrinology Drug Consumption from 2014-20204.3.4.3 Latin America Endocrinology Drug Import and Export from 2014-20204.3.4.4 Latin America Endocrinology Drug Value ($) and Growth (%) by Type from 2019-20204.3.4.5 Latin America Endocrinology Drug Value ($) and Growth (%) by Application from 2019-20204.3.4.6 Latin America Endocrinology Drug Value ($) and Growth (%) by Countries from 2019-20204.3.4.7 Top Latin America Endocrinology Drug Participants Value ($) and Market Share (%) in 20194.3.5 Middle East & Africa Endocrinology Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)4.3.5.1 Middle East & Africa Endocrinology Drug Production from 2014-20204.3.5.2 Middle East & Africa Endocrinology Drug Consumption from 2014-20204.3.5.3 Middle East & Africa Endocrinology Drug Import and Export from 2014-20204.3.5.4 Middle East & Africa Endocrinology Drug Value ($) and Growth (%) by Type from 2019-20204.3.5.5 Middle East & Africa Endocrinology Drug Value ($) and Growth (%) by Application from 2019-20204.3.5.6 Middle East & Africa Endocrinology Drug Value ($) and Growth (%) by Countries from 2019-20204.3.5.7 Top Middle East & Africa Endocrinology Drug Participants Value ($) and Market Share (%) in 20195.

Competitive Intelligence – Company Profiles5.1 GSK5.1.1 GSK Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.1.2 GSK Sales, Growth Rate and Global Market Share from 2014-20205.2 Novo Nordisk AS5.2.1 Novo Nordisk AS Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.2.2 Novo Nordisk AS Sales, Growth Rate and Global Market Share from 2014-20205.3 Allergan5.3.1 Allergan Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.3.2 Allergan Sales, Growth Rate and Global Market Share from 2014-20205.4 AstraZeneca PLC5.4.1 AstraZeneca PLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.4.2 AstraZeneca PLC Sales, Growth Rate and Global Market Share from 2014-20205.5 Merck & Co5.5.1 Merck & Co Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.5.2 Merck & Co Sales, Growth Rate and Global Market Share from 2014-20205.6 Sanofi SA5.6.1 Sanofi SA Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.6.2 Sanofi SA Sales, Growth Rate and Global Market Share from 2014-20205.7 Roche5.7.1 Roche Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.7.2 Roche Sales, Growth Rate and Global Market Share from 2014-20205.8 Bayer5.8.1 Bayer Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.8.2 Bayer Sales, Growth Rate and Global Market Share from 2014-20205.9 Novartis5.9.1 Novartis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.9.2 Novartis Sales, Growth Rate and Global Market Share from 2014-20205.10 AbbVie Inc.5.10.1 AbbVie Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.10.2 AbbVie Inc.

collect
0
Siya Pathriya 2021-02-18
img

According to the recent report published by Research Corridor, the Global Endocrinology Hormone Reagents Market is expected to provide sustainable growth opportunities during the forecast period from 2020 to 2027.

This latest industry research study analyzes the Endocrinology Hormone Reagents market by various product segments, applications, regions and countries while assessing regional performances of numerous leading market participants.

The report titled "Endocrinology Hormone Reagents Market - Global Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast - 2020 – 2027" offers a holistic view of the Endocrinology Hormone Reagents industry encompassing numerous stakeholders including raw material suppliers, providers, distributors, consumers and government agencies, among others.

Furthermore, the report includes detailed quantitative and qualitative analysis of the global Endocrinology Hormone Reagents market considering market history, product development, regional dynamics, competitive landscape, and key success factors (KSFs) in the industry.

Browse Full report on Global Endocrinology Hormone Reagents Market report at  https://www.researchcorridor.com/endocrinology-hormone-reagents-market/ The report includes a deep-dive analysis of key countries including the U.S., Canada, the U.K., Germany, France, China, Japan, India, Australia, Mexico, Brazil and South Africa, among others.

Thereby, the report identifies unique growth opportunities across the world based on trends occurring in various developed and developing economies.

collect
0
watsone us 2020-06-23

Dr. Ahmad Mubaslat is board certified in internal medicine and board certified in Endocrinology, diabetes and metabolic diseases.He graduated medical school from Jordan University in Amman, Jordan.

Dr. Mubaslat concluded his internal medicine residency training at Brown University medical school in Providence, Rhode Island.

He later on completed an endocrinology fellowship at the Phoenix City Wide Endocrine program, Arizona State University in Phoenix, Arizona.

Dr. Mubaslat practiced in Amman, Jordan for the past two years where he established the first private diabetes center in Jordan, Khalidi DC, served as faculty at the internal medicine residency program and the endocrinology fellowship program at Jordan Hospital, as well as consulted on the planning and design for the diabetes and endocrinology department at Abdali Medical Center, a regional medical center that launched recently in Amman, Jordan.St.

collect
0
Pavan Ishi 2021-11-11

Gallium-68 Market: IntroductionAccording to the report, the global gallium-68 market was valued at ~US$ 100 Mn in 2020.

The most popular applications of gallium-68 are for prostate cancer imaging (68Ga-PSMA) and neuroendocrine tumors (68Ga-peptides such as DOTA-TATE, DOTA-TOC, and DOTA-NOC).Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=82334Rise in popularity of gallium-68 as a routinely used radioisotope in clinical PET imaging facilities and increase in prevalence of cancer are key factors that are projected to drive the global gallium-68 market during the forecast period.

Increase in awareness about NETs as well as advancements in nuclear medicine propels the gallium-68 market in North America.The gallium-68 market in Asia Pacific is estimated to expand at a CAGR of ~10% from 2021 to 2031, due to rise in importance of nuclear medicine in several medical disciplines, including cardiology, oncology, and endocrinology coupled with rapidly improving healthcare infrastructure in the region.Request for Analysis of COVID19 Impact on Gallium-68 Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=82334Rise in Prevalence of Prostate Cancer to Drive MarketThe prevalence of prostate cancer has increased across the globe due to a change in dietary habits.

Prostate cancer is typically diagnosed with biopsy and its risk is classified by the concentration of prostate-specific antigen in serum, Gleason score, and the clinical stage.Structural imaging techniques, such as MRI, are beneficial in assessing the intraprostatic progression of the disease.

Therefore, rise in prevalence of prostate cancer is likely to boost the demand for PET imaging utilizing gallium-68 radionucleotide, and subsequently, drives the market during the forecast period.Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=82334Hospitals Major End UsersIn terms of end user, the global gallium-68 market has been split into diagnostic centers, hospitals, and others.

The increase in use of gallium-68 radiopharmaceuticals in the diagnosis of diseases related to cardiology, respiratory, and urology fuels the market in Europe.The gallium-68 market in Asia Pacific is projected to expand at a rapid pace in the near future.

collect
0
erica mary 2020-06-23
img

Dr. Ahmad Mubaslat is board certified in internal medicine and board-certified in Endocrinology, diabetes, and metabolic diseases.He graduated medical school from Jordan University in Amman, Jordan.

Dr. Mubaslat concluded his internal medicine residency training at Brown University medical school in Providence, Rhode Island.

He later on completed an endocrinology fellowship at the Phoenix City Wide Endocrine program, Arizona State University in Phoenix, Arizona.Dr.

Mubaslat served as the head of diabetes and endocrine department at Self Regional Medical Center in Greenwood, South Carolina from 2005 through 2008.

He then headed the Diabetes and metabolic unit at Research Medical Center, Kansas City, Missouri from 2010 through 2017.Dr.

Mubaslat practiced in Amman, Jordan for the past two years where he established the first private diabetes center in Jordan, Khalidi DC, served as faculty at the internal medicine residency program and the endocrinology fellowship program at Jordan Hospital, as well as consulted on the planning and design for diabetes and endocrinology department at Abdali Medical Center, a regional medical center that launched recently in Amman, Jordan.St.

collect
0
genvio 2021-05-04
img

Conferences provide a great insight into the progress made in a particular field.

The objective of the Diabetes and Endocrinology Conference held by Genvio Conferences is to magnify the achievements and presentations made in the field of Science and Technology, Pharma, Engineering and Clinical.

The formal discussions and presentations held in the conferences help in future collaborations and define the scientific careers of the attendees.

The experts contribute by presenting their works and contributions towards the diagnosis and treatment of such diseases.

Reasons related to hormonal imbalance in the human body that contribute towards the development of such disorder are mentioned and related treatments are also discussed.

The Diabetes and Endocrinology Conference also discusses thyroid disorders and the need for regular clinical observations that leads to better management results of the disorder.The World Congress on Diabetes and Endocrinology is planned for September 15th and 16th, 2021 in Rome.

collect
0
seo mypassion12 2021-10-30

Meanwhile, our patients have now been introduced to testosterone and individual growth hormone peptides for around 10 years, and have seen increased insulin opposition, alongside good body composition improvements and weight loss.

Fat loss alone usually adjusts Form II Diabetes.Many people do not kigtropin understand that Form II diabetes is often brought on by improvements in hormone degrees The mix of testosterone alternative, along with a new peptide GHRP-6 which has been developed to instigate the launch of one's own individual development hormone, coupled with a wholesome low-glycemic catalog diet, quickly reverses Form II Diabetes.The brand new peptide is GHRP-6 and can be obtained by prescription through qualified compounding pharmacies.

It functions as a Individual Growth Hormone releaser within the individual body.

Among the options that come with the integrative medication and interventional endocrinology we training at Doctor's Age Administration is that individuals realize the significance of taking a look at your complete body and life style to address wellness problems.

This is a greater over all program than prescribing medications to disguise the apparent symptoms of the actual problem.Though expected, we all come in rejection about aging.

Once we era, we often hope that people could go back to younger and fit variation of ourselves.

collect
0
Charlie Warren 2021-01-11
img
Visen will use the new funds to accelerate the clinical development, manufacturing, and commercialization of its three endocrinology drug products.
collect
0
genvio 2021-05-12
img

Medical meetings are held to enhance the respective field with new ideas, diagnostic methods, and treatment alternatives.

The team at Genvio provides an excellent platform for the experts to share their ideas.

They exchange the research outcomes and plan ways to execute and incorporate the findings to treat chronic diseases.

The World Congress on Diabetes and Endocrinology is already planned for the 15th -16th September 2021 in Rome, Italy.

These days will feature symposiums, workshops, keynote sessions supervised by experienced speakers.

The dissemination of knowledge is executed with perfection in the Diabetes and Endocrinology Conference.

collect
0
David Bloomquist 2018-07-30

Best Pediatrician and Pediatrics Endocrinologist Doctor in Amman, Jordan.

Healthcare provider with 36 years of experience.

Specialties: Pediatrics, Pediatrics Endocrinology and Diabetes ETC.

collect
0
providencemedicalgrp 2021-11-26
img
The Comprehensive Diabetes Care Program at Providence medical Center offers complete outpatient services including diagnostic services. We have the best diabetes specialist doctor in Thornton, Book an appointment today!  
jhon kerry 2021-10-29
The global Home Infusion Therapy Market is anticipated to grow at a significant CAGR during the forecast period. Home infusion therapy is an integral part of professional practice in developed countries. Though the patients’ scenarios are different under various circumstances, a considerable amount of risk is always involved. The nature of home infusion therapy is not only limited to patient care and device, but also it actively involves accumulation of consumables and enactment of quality improvement and research activities. Medical practices inclined towards patient betterment are expected to gain a huge traction in the forecast period. Application segment includes endocrinology, parenteral nutrition, and hydration therapy.
Healthy PCOS 2021-11-11
img

According to a study by Gynecology Endocrinology, women with polycystic ovarian syndrome (PCOS) are 19 times more likely to have a magnesium deficiency.There are a number of reasons why magnesium deficiency is so common among women with PCOS.But it’s likely to be due to some combination between poor soil concentrations of magnesium that lead to magnesium deficient foods, stress, lack of fruits and vegetables, certain medications such as birth control, and insulin resistance.Benefits Of Magnesium For PCOSWhat Is Magnesium?Magnesium is the fourth most abundant mineral in the body.It is naturally present in many foods, added to other food products, available as a dietary supplement, and present in some medicines.Its importance is demonstrated through its involvement as a cofactor in more than 600 enzyme systems that regulate important reactions in the body.Notable reactions with which it is involved include:• Blood glucose control• Blood pressure regulation• Creating proteins from amino acids (protein synthesis); essential for muscle development• Regulating neurotransmitters (brain chemicals — responsible for your mood)• Converting food into energy (cellular energy production).All of the above reactions contribute to the health of your brain and body, which makes magnesium an essential mineral; especially for those who have PCOS and are likely to have a deficiency.Magnesium, then, is a core staple supplement for women with PCOS.However, it is not merely because of its involvement in reactions within your body.It’s also because of its ability to help a range of PCOS symptoms, some of which are seen as almost unbearable.Without further ado, let’s explore why you should consider supplementing with magnesium.

Wiseguy1011 2021-07-14

Due to the high popularity of this product/service in North America and Asia, the growth trend of Endocrinology Drug in recent years and the growth of consumers' demand is expected to drive the global Endocrinology Drug market.ALSO READ:  http://www.marketwatch.com/story/global-endocrinology-drug-market-size-share-value-and-competitive-landscape-2020-2021-05-04Geographically, the global Endocrinology Drug market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.North America, Asia and Europe have significant position in the this market, big players operating in there.

The U.S. is accounting for a major share of the total Endocrinology Drug market in North America.Significant participants active in the global Endocrinology Drug market include: GSK, Novo Nordisk AS, Allergan, AstraZeneca PLC, Merck & Co, Sanofi SA, Roche, Bayer, Novartis, AbbVie Inc., Pfizer, Eli Lilly and Co....ALSO READ:  http://www.marketwatch.com/story/june-2021-report-on-global-bed-with-storage-market-size-share-value-and-competitive-landscape-2021-2026-2021-06-17Global Endocrinology Drug Market Segmentation:Endocrinology Drug market, by Endocrinology Drug type:Type 1Type 2Type 3…Endocrinology Drug market, by Application:Application 1Application 2Application 3…ALSO READ:  http://www.marketwatch.com/story/june-2021-report-on-global-iot-spending-in-manufacturing-market-overview-size-share-and-trends-2021-2026-2021-06-17Endocrinology Drug Market Research Report 2014-2026, by region:North AmericaThe U.S.CanadaEuropeGermanyUKFranceItalySpainRest of EuropeLatin AmericaMexicoBrazilArgentinaPan Asia PacificChinaJapanSouth KoreaSouth East Asia RegionIndiaAustraliaMiddle East and AfricaSaudi ArabiaUAEQatarEgyptNigeriaSouth AfricaRest of MEAThe database is running updated by a group of research experts to always reflect the latest trends and information.ALSO READ:  http://www.marketwatch.com/story/pre-packed-fruit-and-vegetables-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2020-2026-2021-06-21Table of Contents1.

Introduction1.1 Definition of the Market1.2 Research Purpose1.3 Scope of the Study1.4 Stakeholders1.5 Geography Coverage1.6 Currency Under Consideration1.7 Volume Units1.8 Review Cycle1.9 Summary and Key Findings of the Research2 Research Methodology2.1 Research Data2.1.1 Secondary Data2.1.2 Primary Data2.2 Market Size Estimation2.2.1 Bottom-Up Approach2.2.2 Top-Down Approach (Involves time, Space, and Persons)2.3 Data Triangulation2.4 Assumptions2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research2.6 Limitations of Our Study2.7 Scene Based Modeling2.8 Covid-19 Impact/Evaluation3.

Market Dynamics3.1 Driving Factors3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa3.1.2 Increasing Use of Endocrinology Drug by Different End-User/Applications3.2 Restraints and Challenges in the Market3.3 OpportunitiesALSO READ:  http://www.marketwatch.com/story/electric-bikes-and-folding-bikes-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2020-2026-2021-06-204.

Global Endocrinology Drug Market-Segmentation4.1 By Type4.1.1 Type 14.1.2 Type 24.1.3 Type 34.2 By End-User/Application Industry4.2.1 Application 14.2.2 Application 24.2.3 Application 34.3 By Geography4.3.1 North America Endocrinology Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)4.3.1.1 North America Endocrinology Drug Production from 2014-20204.3.1.2 North America Endocrinology Drug Consumption from 2014-20204.3.1.3 North America Endocrinology Drug Import and Export from 2014-20204.3.1.4 North America Endocrinology Drug Market Value ($) and Growth (%) by Type from 2019-20204.3.1.5 North America Endocrinology Drug Market Value ($) and Growth (%) by Application from 2019-20204.3.1.6 North America Endocrinology Drug Market Value ($) and Growth (%) by Countries from 2019-20204.3.1.7 Top North America Endocrinology Drug Participants Value ($) and Market Share (%) in 20194.3.2 Europe Endocrinology Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)4.3.2.1 Europe Endocrinology Drug Production from 2014-20204.3.2.2 Europe Endocrinology Drug Consumption from 2014-20204.3.2.3 Europe Endocrinology Drug Import and Export from 2014-20204.3.2.4 Europe Endocrinology Drug Market Value ($) and Growth (%) by Type from 2019-20204.3.2.5 Europe Endocrinology Drug Value ($) and Growth (%) by Application from 2019-20204.3.2.6 Europe Endocrinology Drug Market Value ($) and Growth (%) by Countries from 2019-20204.3.2.7 Top Europe Endocrinology Drug Participants Value ($) and Market Share (%) in 20194.3.3 Asia-Pacific Endocrinology Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)4.3.3.1 Asia-Pacific Endocrinology Drug Production from 2014-20204.3.3.2 Asia-Pacific Endocrinology Drug Consumption from 2014-20204.3.3.3 Asia-Pacific Endocrinology Drug Import and Export from 2014-20204.3.3.4 Asia-Pacific Endocrinology Drug Value ($) and Growth (%) by Type from 2019-20204.3.3.5 Asia-Pacific Endocrinology Drug Value ($) and Growth (%) by Application from 2019-20204.3.3.6 Asia-Pacific Endocrinology Drug Value ($) and Growth (%) by Countries from 2019-20204.3.3.7 Top Asia-Pacific Endocrinology Drug Participants Value ($) and Market Share (%) in 20194.3.4 Latin America Endocrinology Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)4.3.4.1 Latin America Endocrinology Drug Production from 2014-20204.3.4.2 Latin America Endocrinology Drug Consumption from 2014-20204.3.4.3 Latin America Endocrinology Drug Import and Export from 2014-20204.3.4.4 Latin America Endocrinology Drug Value ($) and Growth (%) by Type from 2019-20204.3.4.5 Latin America Endocrinology Drug Value ($) and Growth (%) by Application from 2019-20204.3.4.6 Latin America Endocrinology Drug Value ($) and Growth (%) by Countries from 2019-20204.3.4.7 Top Latin America Endocrinology Drug Participants Value ($) and Market Share (%) in 20194.3.5 Middle East & Africa Endocrinology Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)4.3.5.1 Middle East & Africa Endocrinology Drug Production from 2014-20204.3.5.2 Middle East & Africa Endocrinology Drug Consumption from 2014-20204.3.5.3 Middle East & Africa Endocrinology Drug Import and Export from 2014-20204.3.5.4 Middle East & Africa Endocrinology Drug Value ($) and Growth (%) by Type from 2019-20204.3.5.5 Middle East & Africa Endocrinology Drug Value ($) and Growth (%) by Application from 2019-20204.3.5.6 Middle East & Africa Endocrinology Drug Value ($) and Growth (%) by Countries from 2019-20204.3.5.7 Top Middle East & Africa Endocrinology Drug Participants Value ($) and Market Share (%) in 20195.

Competitive Intelligence – Company Profiles5.1 GSK5.1.1 GSK Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.1.2 GSK Sales, Growth Rate and Global Market Share from 2014-20205.2 Novo Nordisk AS5.2.1 Novo Nordisk AS Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.2.2 Novo Nordisk AS Sales, Growth Rate and Global Market Share from 2014-20205.3 Allergan5.3.1 Allergan Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.3.2 Allergan Sales, Growth Rate and Global Market Share from 2014-20205.4 AstraZeneca PLC5.4.1 AstraZeneca PLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.4.2 AstraZeneca PLC Sales, Growth Rate and Global Market Share from 2014-20205.5 Merck & Co5.5.1 Merck & Co Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.5.2 Merck & Co Sales, Growth Rate and Global Market Share from 2014-20205.6 Sanofi SA5.6.1 Sanofi SA Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.6.2 Sanofi SA Sales, Growth Rate and Global Market Share from 2014-20205.7 Roche5.7.1 Roche Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.7.2 Roche Sales, Growth Rate and Global Market Share from 2014-20205.8 Bayer5.8.1 Bayer Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.8.2 Bayer Sales, Growth Rate and Global Market Share from 2014-20205.9 Novartis5.9.1 Novartis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.9.2 Novartis Sales, Growth Rate and Global Market Share from 2014-20205.10 AbbVie Inc.5.10.1 AbbVie Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)5.10.2 AbbVie Inc.

watsone us 2020-06-23

Dr. Ahmad Mubaslat is board certified in internal medicine and board certified in Endocrinology, diabetes and metabolic diseases.He graduated medical school from Jordan University in Amman, Jordan.

Dr. Mubaslat concluded his internal medicine residency training at Brown University medical school in Providence, Rhode Island.

He later on completed an endocrinology fellowship at the Phoenix City Wide Endocrine program, Arizona State University in Phoenix, Arizona.

Dr. Mubaslat practiced in Amman, Jordan for the past two years where he established the first private diabetes center in Jordan, Khalidi DC, served as faculty at the internal medicine residency program and the endocrinology fellowship program at Jordan Hospital, as well as consulted on the planning and design for the diabetes and endocrinology department at Abdali Medical Center, a regional medical center that launched recently in Amman, Jordan.St.

erica mary 2020-06-23
img

Dr. Ahmad Mubaslat is board certified in internal medicine and board-certified in Endocrinology, diabetes, and metabolic diseases.He graduated medical school from Jordan University in Amman, Jordan.

Dr. Mubaslat concluded his internal medicine residency training at Brown University medical school in Providence, Rhode Island.

He later on completed an endocrinology fellowship at the Phoenix City Wide Endocrine program, Arizona State University in Phoenix, Arizona.Dr.

Mubaslat served as the head of diabetes and endocrine department at Self Regional Medical Center in Greenwood, South Carolina from 2005 through 2008.

He then headed the Diabetes and metabolic unit at Research Medical Center, Kansas City, Missouri from 2010 through 2017.Dr.

Mubaslat practiced in Amman, Jordan for the past two years where he established the first private diabetes center in Jordan, Khalidi DC, served as faculty at the internal medicine residency program and the endocrinology fellowship program at Jordan Hospital, as well as consulted on the planning and design for diabetes and endocrinology department at Abdali Medical Center, a regional medical center that launched recently in Amman, Jordan.St.

seo mypassion12 2021-10-30

Meanwhile, our patients have now been introduced to testosterone and individual growth hormone peptides for around 10 years, and have seen increased insulin opposition, alongside good body composition improvements and weight loss.

Fat loss alone usually adjusts Form II Diabetes.Many people do not kigtropin understand that Form II diabetes is often brought on by improvements in hormone degrees The mix of testosterone alternative, along with a new peptide GHRP-6 which has been developed to instigate the launch of one's own individual development hormone, coupled with a wholesome low-glycemic catalog diet, quickly reverses Form II Diabetes.The brand new peptide is GHRP-6 and can be obtained by prescription through qualified compounding pharmacies.

It functions as a Individual Growth Hormone releaser within the individual body.

Among the options that come with the integrative medication and interventional endocrinology we training at Doctor's Age Administration is that individuals realize the significance of taking a look at your complete body and life style to address wellness problems.

This is a greater over all program than prescribing medications to disguise the apparent symptoms of the actual problem.Though expected, we all come in rejection about aging.

Once we era, we often hope that people could go back to younger and fit variation of ourselves.

genvio 2021-05-12
img

Medical meetings are held to enhance the respective field with new ideas, diagnostic methods, and treatment alternatives.

The team at Genvio provides an excellent platform for the experts to share their ideas.

They exchange the research outcomes and plan ways to execute and incorporate the findings to treat chronic diseases.

The World Congress on Diabetes and Endocrinology is already planned for the 15th -16th September 2021 in Rome, Italy.

These days will feature symposiums, workshops, keynote sessions supervised by experienced speakers.

The dissemination of knowledge is executed with perfection in the Diabetes and Endocrinology Conference.

Shivani Sharma 2021-11-01
img

The global chemiluminescence immunoassay market is expected to reach USD 10.67 billion by 2027, according to a new study by Polaris Market Research.

The report Chemiluminescence Immunoassay Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments {Automated and Semi-automated}, Consumables, Software & Services); By Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease); By End Use; By Regions; Segment Forecast, 2020 – 2027 gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global chemiluminescence immunoassay market is driven by few notable factors such as rapid surge in the COVID- 19 cases, the awareness among the people about timely medical attention, and rapidly improving healthcare infrastructure in terms of rapid testing, which in turn, boosting the chemiluminescence immunoassay industry growth.

Chemiluminescence immunoassay solutions are also used for detection of numerous severe diseases including autoimmune disease, cancer, and diabetes, among others.

Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/chemiluminescence-immunoassay-market/request-for-sample  The global chemiluminescence immunoassay industry is segmented on the basis of product, application, end-use, and region.

Based on application, the market is classified as therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease, autoimmune disease, and others.

Dhirtek Business Research 2021-09-27

REQUEST A SAMPLE REPORTAccording to the latest research report published by Dhirtek Business Research, the global endocrinology drugs market report provides detailed information on the factors driving the growth of the endocrinology drugs market.

The COVID-19 has a significant impact on the global economy.

This pandemic is having an impact on various sectors of the economy.

It predicts that the global economy will suffer as a result of the loss of trillions of dollars.

The report includes a chapter that examines the effect of COVID-19 on the endocrinology drugs market in depth.To compete in a competitive market, the companies must identify product opportunities based on their strengths.

This study provides a platform for understanding the various exciting and rising prospects in the field of endocrinology drugs, and it will help every producer, distributor, or even user understand and succeed in this burgeoning industry.Obtain a Sample Report and the Table of Content for the Endocrinology Drugs Market Report: https://www.dhirtekbusinessresearch.com/market-report/Endocrinology-Drugs-Market/request-for-sample-reportStudy Goals and Objectives of Global Endocrinology Drugs MarketThe report provides information on the market impact of endocrinology drugs.

Deepak Karde 2021-08-06

Endocrinology Drug Market Market Introduction & Scope:Introspective Market Research has conducted a thorough and extensive analysis of the global Endocrinology Drug Market market.

It is a complete research study and industry analysis of the market to understand the market influencing market demand, growth, trend analysis and factors.Also, it strategically profiles the key players and comprehensively analyzes their development, mergers and acquisition and the R investment done by the competitors.To define, describe and forecast the market by product type, market and key regions.The Endocrinology Drug Market market report comprises of:past acquisition strategies supportedactivities taken to remove competitive barriersactions data to resolve deficient data issueschanges in the market place (suppliers, trends, technologies)past acquisition historyLeading players involved in the Endocrinology Drug Market Market includes:Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, AbbVieTo identify the key drivers and the competitors’ insights, Request a Sample @:https://introspectivemarketresearch.com/request/11035Global Endocrinology Drug Market Market: Key CatalystsIntrospective Market Research in a recent report focused on providing all the market potentials and drivers influencing the market.

The opportunities and constraints for the market are presented after reviewing all market estimates and details provided by reliable sources for the Endocrinology Drug Market market.

In addition to a detailed description of the key factors, the report provides a complete understanding of the challenges, opportunities and factors that are influencing the future market growth.The analysis also divides the Endocrinology Drug Market Market on the grounds of main product type:Oral, InjectionThe analysis also divides the Endocrinology Drug Market Market on the applications:Application 1, Application 2, OtherDriver Analysis: After surveys, data mining and collecting from paid and real sources, the results for the global Endocrinology Drug Market market are presented with the utmost understanding and factors considered for the market growth.

IMR's reports will be updated over the next few years, providing customers with accurate data and value on market trends using the same size and forecast variable.Get Discount on Full Report of Endocrinology Drug Market Market @: https://introspectivemarketresearch.com/discount/11035Restraints: The specific types of issues a manufacturer or supplier is dealing with in relation to the global Endocrinology Drug Market market is analyzed in the report to ensure that customers have a clear and easy-to-understand overview of the market and trends.

The IMR market research report provides a detailed analysis of mergers and acquisitions, providing opportunities to win customers in the industry domain.The full overview of the report is aimed at providing an analysis of the market to help customers know a detailed version of the threats of new entrants, supply and demand chain analysis, and the challenges facing the market.

Siya Pathriya 2021-02-18
img

According to the recent report published by Research Corridor, the Global Endocrinology Hormone Reagents Market is expected to provide sustainable growth opportunities during the forecast period from 2020 to 2027.

This latest industry research study analyzes the Endocrinology Hormone Reagents market by various product segments, applications, regions and countries while assessing regional performances of numerous leading market participants.

The report titled "Endocrinology Hormone Reagents Market - Global Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast - 2020 – 2027" offers a holistic view of the Endocrinology Hormone Reagents industry encompassing numerous stakeholders including raw material suppliers, providers, distributors, consumers and government agencies, among others.

Furthermore, the report includes detailed quantitative and qualitative analysis of the global Endocrinology Hormone Reagents market considering market history, product development, regional dynamics, competitive landscape, and key success factors (KSFs) in the industry.

Browse Full report on Global Endocrinology Hormone Reagents Market report at  https://www.researchcorridor.com/endocrinology-hormone-reagents-market/ The report includes a deep-dive analysis of key countries including the U.S., Canada, the U.K., Germany, France, China, Japan, India, Australia, Mexico, Brazil and South Africa, among others.

Thereby, the report identifies unique growth opportunities across the world based on trends occurring in various developed and developing economies.

Pavan Ishi 2021-11-11

Gallium-68 Market: IntroductionAccording to the report, the global gallium-68 market was valued at ~US$ 100 Mn in 2020.

The most popular applications of gallium-68 are for prostate cancer imaging (68Ga-PSMA) and neuroendocrine tumors (68Ga-peptides such as DOTA-TATE, DOTA-TOC, and DOTA-NOC).Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=82334Rise in popularity of gallium-68 as a routinely used radioisotope in clinical PET imaging facilities and increase in prevalence of cancer are key factors that are projected to drive the global gallium-68 market during the forecast period.

Increase in awareness about NETs as well as advancements in nuclear medicine propels the gallium-68 market in North America.The gallium-68 market in Asia Pacific is estimated to expand at a CAGR of ~10% from 2021 to 2031, due to rise in importance of nuclear medicine in several medical disciplines, including cardiology, oncology, and endocrinology coupled with rapidly improving healthcare infrastructure in the region.Request for Analysis of COVID19 Impact on Gallium-68 Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=82334Rise in Prevalence of Prostate Cancer to Drive MarketThe prevalence of prostate cancer has increased across the globe due to a change in dietary habits.

Prostate cancer is typically diagnosed with biopsy and its risk is classified by the concentration of prostate-specific antigen in serum, Gleason score, and the clinical stage.Structural imaging techniques, such as MRI, are beneficial in assessing the intraprostatic progression of the disease.

Therefore, rise in prevalence of prostate cancer is likely to boost the demand for PET imaging utilizing gallium-68 radionucleotide, and subsequently, drives the market during the forecast period.Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=82334Hospitals Major End UsersIn terms of end user, the global gallium-68 market has been split into diagnostic centers, hospitals, and others.

The increase in use of gallium-68 radiopharmaceuticals in the diagnosis of diseases related to cardiology, respiratory, and urology fuels the market in Europe.The gallium-68 market in Asia Pacific is projected to expand at a rapid pace in the near future.

genvio 2021-05-04
img

Conferences provide a great insight into the progress made in a particular field.

The objective of the Diabetes and Endocrinology Conference held by Genvio Conferences is to magnify the achievements and presentations made in the field of Science and Technology, Pharma, Engineering and Clinical.

The formal discussions and presentations held in the conferences help in future collaborations and define the scientific careers of the attendees.

The experts contribute by presenting their works and contributions towards the diagnosis and treatment of such diseases.

Reasons related to hormonal imbalance in the human body that contribute towards the development of such disorder are mentioned and related treatments are also discussed.

The Diabetes and Endocrinology Conference also discusses thyroid disorders and the need for regular clinical observations that leads to better management results of the disorder.The World Congress on Diabetes and Endocrinology is planned for September 15th and 16th, 2021 in Rome.

Charlie Warren 2021-01-11
img
Visen will use the new funds to accelerate the clinical development, manufacturing, and commercialization of its three endocrinology drug products.
David Bloomquist 2018-07-30

Best Pediatrician and Pediatrics Endocrinologist Doctor in Amman, Jordan.

Healthcare provider with 36 years of experience.

Specialties: Pediatrics, Pediatrics Endocrinology and Diabetes ETC.